Home >> Conferences >> 2015 World Congress of Regenerative Medicine & Stem Cell-Shanghai
Conferences

2015 World Congress of Regenerative Medicine & Stem Cell-Shanghai

02-27-2015 11:54


Theme: A Golden Key to Regeneration;
Time: November 18-20, 2015;
Place: Shanghai, China;
Hosting Organization: Information Research Center of International Talents, SAFEA;
Supporting Organization: BIT Congress Inc. and Foreign Experts Databank of SAFEA-Dalian Branch
Executive Chair: Dr. Xiaodan Mei, President of BIT Congress Inc., China
Contact Information: http://www.bitcongress.com/rmsc-china2015/MediaPartners.asp

Introduction to Shanghai RMSC-2015
    Regenerative medicine and stem cell constitute a huge industry of medical technology and services, which is led to the Multi-disciplinary Cross Action and cooperation, such as Basic Sciences, Novel Technologies, and Clinical Translations. It has a perspective to form a biotechnology industry chain with the development of regenerative medicine industry as the center, which will be one of the high-tech industries with the huge potential in 21st century. Entering its 8th year, World Congress of Regenerative Medicine & Stem Cell has been grown substantially, Shanghai RMSC-2015 will provide all participants with resources, information and advice they might need to aid their research, strategic business planning, decision making and future professional developments.

Program Layout:
Plenary Keynote Forum
Track 1: A Revolution in Stem Cell Biotherapy
Track 2: Miraculous Stem Cell Biology
Track 3: Breaking Research and Applications in Clinical Trials
Track 4: Perpetual Regeneration: Stem cell and Tissue Engineering Young Investigator Forum
Business & Social Events

Renowned Speakers of RMSC-2015 Korea:
Dr. Alain Vertes, Managing Director, NxR Biotechnologies, Switzerland; Sloan Fellow, London Business School, UK
Dr. Alexander Kharazi, Chief Technology Officer, Stemedica Cell Technologies, Inc., USA
Dr. Anand Gadre, Director, Stem Cell Instrumentation Foundry, University of California, USA
Dr. Anand S. Srivastava, Chairman and Co-founder, Global Institute of Stem Cell Therapy and Research, USA
Dr. Araz Raoof, Vice President, Global Functional Head at Janssen, Pharmaceutical Companies of Johnson and Johnson, Belgium
Dr. Anton C. Krucky, President & CEO, Tissue Genesis, Inc., USA
Dr. Anthony E. Ting, Senior Director, Regenerative Medicine, Head, Cardiovascular and Pulmonary R&D, Athersys, Inc., USA
Dr. Ken Williams, Professor, The Irvine Institute of Medicine and Cosmetic Surgery, USA
Dr. James Lovgren, Chief Business Officer, ORIG3N, USA
Dr. Jeanann S. BOYCE, Professor, Montgomery College, USA
Dr. Johan Hyllner, Chief Scientific Officer, Cell Therapy Catapult, UK
Dr. Kwang-Sup Soh, Professor, Seoul National University, South Korea
Dr. Miroslaw Janowski, Assistant Professor, Johns Hopkins University, USA
Dr. Miroslaw Janowski, Assistant Professor, Johns Hopkins University, USA
Dr. Rahul Aras, President, Juventas Therapeutics, USA
Dr. Ralf Huss, Chief Scientific Officer, apceth GmbH & Co. KG, Germany
Dr. Ross Macdonald, Managing Director and Chief Executive Officer, Cynata Therapeutics Ltd, Australia
Dr. Senyon Choe, Professor, The Salk Institute, USA
Dr. Seong-Jin Kim, President, CHA Research Institutes; Director, CHA Cancer Institute, South Korea
Dr. Shai Meretzki, Chairman, Biological Industries Ltd, Israel
Dr. Wolf-D. Grimm, Professor, University of Witten/Herdecke, Germany; Professor, Stavropol State Medical University, Russia
Dr. Yi Ren, Professor, Department of Biomedical Science, Florida State University College of Medicine, USA
Dr. Young-Ho Lee, Chairman, Department of Pediatrics, Hanyang University Medical Center, South Korea
 

Copyright © 2013 International Union of Science & Education All rights reserved.